Bulletin
Investor Alert

London Markets Open in:

Cerecor Inc.

NAS: CERC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 10, 2020, 7:59 p.m.

/zigman2/quotes/201368871/composite

$

2.57

Change

0.00 0.00%

Volume

Volume 2,063

Quotes are delayed by 20 min

/zigman2/quotes/201368871/composite

Previous close

$ 2.56

$ 2.57

Change

+0.01 +0.39%

Day low

Day high

$2.52

$2.59

Open

52 week low

52 week high

$1.52

$6.19

Open

Joseph M. Miller

Joseph M. Miller occupies the position of Chief Financial Officer of Aurinia Pharmaceuticals, Inc. Mr. Miller is also on the board of Cerecor, Inc.

Mr. Miller previously was Chief Financial Officer & Vice President-Finance of Eppendorf-5 Prime, Inc., Senior Director-Accounting at Qiagen Genomics, Inc. and Vice President-Finance of Sucampo Pharmaceuticals, Inc.

Joseph M. Miller received an undergraduate degree from Villanova University.

Transactions

Date Shares Transaction Value
06/08/2020 4,472   Derivative/Non-derivative trans. at $3.22 per share. 14,400
12/10/2019 2,598   Acquisition at $2.85 per share. 7,404
06/07/2019 3,723   Derivative/Non-derivative trans. at $4.85 per share. 18,057
07/12/2018 45,000   Award at $0 per share. 0

Officers and Executives

Mr. Michael F. Cola
Chief Executive Officer & Director
Mr. Christopher Sullivan
Chief Financial & Accounting Officer
Dr. Garry Arthur Neil
Chief Medical Officer
Dr. H. Jeffrey Wilkins
Chief Development Officer
Dr. Bernadine Heather Fraser
VP-Clinical Operations & Project Management
Mr. Joseph M. Miller
Director
Mr. James A. Harrell
Chief Commercial Officer
Dr. Sol J. Barer
Chairman
Dr. Suzanne Louise Bruhn
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Mr. Phil Gutry
Independent Director
Mr. Steven Joseph Boyd
Independent Director
Link to MarketWatch's Slice.